Adalyon

This advanced speech analytics platform employs proprietary behavioral biomarkers and AI-powered conversational interfaces to monitor cognitive, emotional, and behavioral changes continuously during clinical trials, enabling early detection of treatment response and dropout risk. Its key features include natural voice journaling with guided prompts, real-time behavioral and mood insights through acoustic and semantic analysis, automated psychometric assessments, and seamless integration with existing trial systems—all designed to improve patient engagement, reduce clinical trial timelines by up to 30%, and improve data accuracy while ensuring regulatory compliance and solid data privacy protections. It is primarily intended for clinical researchers, pharmaceutical companies, and healthcare organizations seeking to optimize trial efficiency, strengthen regulatory submissions, and gain objective, real-time insights into patient behavioral dynamics across multiple disease areas.

Adalyon 可以在以下位置找到： Behavioral Health Software 类别。